NeuroOne Medical Technologies Corp (NMTC)
1.15
+0.02
(+1.77%)
USD |
NASDAQ |
May 01, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
NeuroOne Medical Technologies Research and Development Expense (Quarterly): 1.483M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.483M |
| September 30, 2023 | 1.779M |
| June 30, 2023 | 1.892M |
| March 31, 2023 | 1.706M |
| December 31, 2022 | 1.564M |
| September 30, 2022 | 1.438M |
| June 30, 2022 | 1.225M |
| March 31, 2022 | 1.205M |
| December 31, 2021 | 1.060M |
| September 30, 2021 | 1.008M |
| June 30, 2021 | 0.9011M |
| March 31, 2021 | 1.081M |
| December 31, 2020 | 0.9342M |
| September 30, 2020 | 0.7847M |
| June 30, 2020 | 0.4472M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3421M |
| December 31, 2019 | 0.5018M |
| September 30, 2019 | 0.4609M |
| June 30, 2019 | 0.4228M |
| March 31, 2019 | 0.4363M |
| December 31, 2018 | 0.2092M |
| June 30, 2018 | 0.2255M |
| March 31, 2018 | 0.105M |
| December 31, 2017 | 0.2349M |
| September 30, 2017 | 0.2717M |
| June 30, 2017 | 0.1567M |
| March 31, 2017 | 0.072M |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.3421M
Minimum
Mar 2020
1.892M
Maximum
Jun 2023
1.065M
Average
1.060M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| DIH Holding US Inc | -- |
| Align Technology Inc | 91.86M |
| ThermoGenesis Holdings Inc | 0.329M |
| SINTX Technologies Inc | 1.824M |
| Nutriband Inc | 0.5515M |